LPI (LP Information)' newest research report, the ﾓOncolytic Virus Drug Treatment Industry Forecastﾔ looks at past sales and reviews total world Oncolytic Virus Drug Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Drug Treatment sales for 2023 through 2029. With Oncolytic Virus Drug Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Drug Treatment industry. This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Drug Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncolytic Virus Drug Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firmsﾒ unique position in an accelerating global Oncolytic Virus Drug Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Drug Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Drug Treatment. The global Oncolytic Virus Drug Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Oncolytic Virus Drug Treatment players cover Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Drug Treatment market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Phase 1 Phase 2 Others Segmentation by application Melanoma Prostate Cancer Breast Cancer Ovarian Cancer Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Amgen Oncolytics Biotech Viralytics Transgene SA Oncolys BioPharma Targovax PsiOxus Therapeutics SillaJen Biotherapeutics Sorrento Therapeutics Lokon Pharma Genelux Corporation Vyriad TILT Biotherapeutics Cold Genesys
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Oncolytic Virus Drug Treatment Market Size 2018-2029
